- Regulatory Status
- RUO
- Other Names
- CD99L2, CD99-L2, CD99 molecule-like 2, CD99 antigen-like 2, CD99 antigen-like protein 2, CD99B, CD99 antigen, MIC2 like 1, MIC2L1, MIC2-like protein 1
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Mouse CD99-L2 supports the adhesion of THP-1 cells in a dose-dependent manner. ED50 for this effect is 45 – 900 ng/mL. -
Stability Testing for recombinant mouse CD99-L2. Recombinant mouse CD99-L2 was aliquoted in PBS, pH 7.2 at 0.2 mg/mL. One aliquot was kept at 4°C (Control), and another was frozen and thawed four times (4x Freeze/Thaw). The samples were tested for their ability to supports the adhesion of THP-1 cells in a dose-dependent manner. The ED50 for this effect is 45 – 900 ng/mL.
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 561414 | 25 µg | 200€ | ||||
| 561416 | 100 µg | 564€ | ||||
CD99-like 2 (CD99-L2) is a highly glycosylated type I transmembrane protein that is expressed on both leukocytes and endothelial cells. CD99-L2 can bind to either homophilic or heterophilic ligands and plays a critical role in the transendothelial migration (TEM) of leukocytes, a key process in inflammation. Inhibition of CD99-L2 has been shown to reduce leukocyte recruitment. Additionally, CD99-L2 is essential for the in vivo TEM of monocytes, neutrophils, and lymphocytes across endothelial cells. Mouse CD99-L2 shares approximately 32% amino acid identity with CD99. Mouse CD99-L2 shares 72% and 85% amino acid identity with human CD99-L2 and rat CD99-L2, respectively. The expression of CD99-L2 on endothelial cells is reported to mediate in vivo cell aggregation and extravasation of lymphocytes, neutrophils and monocytes into inflamed tissue.
Product DetailsProduct Details
- Source
- Recombinant mouse CD99-L2, amino acid Val20-Ala141 (Accession No. Q8BIF0-2) was expressed in 293E cells. The C-terminal includes IEGRMD-mIgG2a-Fc tag.
- Molecular Mass
- The 361 amino acid recombinant protein has a predicted molecular mass of approximately 40 kD. The DTT-reduced and non-reduced proteins migrate at approximately 50 - 62 kD and 80 - 115 kD by SDS-PAGE respectively. The N-terminal amino acid is Val.
- Purity
- ≥ 95%, as determined by Coomassie stained SDS-PAGE.
- Formulation
- 0.22 µm filtered protein solution is in PBS, pH 7.2
- Endotoxin Level
- Less than 0.1 EU per µg protein as determined by the LAL method.
- Concentration
- 25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
- Activity
- ED50 = 45 – 900 ng/mL as measured by its ability to support the adhesion of THP-1 cells.
- Application
-
Bioassay
- Application Notes
-
BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.
Antigen Details
- Structure
- Monomer
- Distribution
-
Expressed in brain, heart, lung, liver, spleen, kidney, stomach, small intestine, skeletal muscle, ovary, thymus, testis and uterus
- Function
- Leukocyte transendothelial migration
- Interaction
- Endothelial cells, monocytes
- Ligand/Receptor
- Paired immunoglobulin like receptors (PILRs), CD99, CD31
- Bioactivity
- Measured by its ability to support the adhesion of THP-1 cells
- Cell Type
- B cells, Endothelial cells, Leukocytes, Neutrophils, T cells
- Biology Area
- Angiogenesis, Cell Adhesion, Cell Motility/Cytoskeleton/Structure, Immuno-Oncology, Immunology, Signal Transduction
- Molecular Family
- CD Molecules
- Antigen References
-
- Goodfellow PN, et al. 1988. Philos Trans R Soc Lond B Biol Sci. 322:145-54.
- Husak Z, et al. 2012. Cell Death Dis. 3:e425.
- Olivia L, et al. 2007. J Immunol. 178:1136.
- Manara MC, et al. 2006. Mol Biol Cell. 17:1910-21.
- Park SH, et al. 2005. Gene. 353:177-88.
- Pasello M, et al. 2018. J Cell Commun Signal. 12:55-68.
- Rocchi A, et al. 2010. J Clin Invest. 120:668-80.
- Schenkel AR, et al. 2002. Nat Immunol. 3:143-50.
- Scotlandi K, et al. 2006. Eur J Cancer. 42:91-6.
- Watson RL, et al. 2015. J Exp Med. 212:1021-41.
- Gene ID
- 171486 View all products for this Gene ID
- UniProt
- View information about CD99-L2 on UniProt.org
Related FAQs
- Why choose BioLegend recombinant proteins?
-
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins. - How does the activity of your recombinant proteins compare to competitors?
-
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
-
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
-
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
-
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
-
Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)
Login / Register 



Follow Us